Deciphering the role of flutamide, fluorouracil, and furomollugin based ionic liquids in potent anticancer agents: Quantum chemical, medicinal, molecular docking and MD simulation studies

IF 2.5 Q2 CHEMISTRY, MULTIDISCIPLINARY
Danish Ali , Muhammad Arif Ali , Muhammad Sarfraz , Afifa Yousuf , Rasham Zulfiqar , Abdul Rauf , Hong-Liang Xu , Muhammad Arshad
{"title":"Deciphering the role of flutamide, fluorouracil, and furomollugin based ionic liquids in potent anticancer agents: Quantum chemical, medicinal, molecular docking and MD simulation studies","authors":"Danish Ali ,&nbsp;Muhammad Arif Ali ,&nbsp;Muhammad Sarfraz ,&nbsp;Afifa Yousuf ,&nbsp;Rasham Zulfiqar ,&nbsp;Abdul Rauf ,&nbsp;Hong-Liang Xu ,&nbsp;Muhammad Arshad","doi":"10.1016/j.rechem.2025.102029","DOIUrl":null,"url":null,"abstract":"<div><div>Ionic liquids (ILs) have emerged as a versatile candidate in medicinal chemistry, electrochemistry catalysis, and biotechnology. In this work, we explored the electronic interionic interactions, stability, and reactivity of FDA approved drug-based cations flutamide <strong>([FT1]<sup>+</sup></strong>, <strong>[FT2]<sup>+</sup>)</strong>, fluorouracil <strong>([FU1]<sup>+</sup>)</strong>, and furomollugin <strong>([FM1]<sup>+</sup></strong>, <strong>[FM2]<sup>+</sup>)</strong>, paired with amino acid <strong>[NH]<sup>−</sup></strong>, nitrate <strong>[NO<sub>3</sub>]<sup>−</sup></strong>, and triflate <strong>[CF<sub>3</sub>]<sup>−</sup></strong> anions, in gas and solvent phases (benzene and water). Frontiers molecular orbitals (FMOs) showed that <strong>[FT1]<sup>+</sup>[NH]<sup>–</sup></strong> exhibits the smaller <em>E</em><sub>gap</sub> on both gas and solvent phase from 5.24 to 4.39 eV, suggesting high reactivity and increasing solubility. Notably, the IL pair <strong>[FT1]<sup>+</sup>[NH]<sup>–</sup></strong> possessed substantial interaction energies in the gas phase (−426.64 kcal/mol), in benzene (−390.24 kcal/mol), and in water (−369.69 kcal/mol), highlighting its potential to disrupt cancer cell growth and exhibit strong anticancer efficacy. The stability of <strong>[FT1]<sup>+</sup>[NH]<sup>–</sup></strong> was further corroborated by significant Gibbs free energy and enthalpy values (−545.30 and −560.36 kcal/mol). Bioinformatics studies reveal that our studied ILs possess superior drug-likeness along with supportive medicinal chemistry parameters. Such as, toxicity evaluation based on the TOX21 pathway confirmed the non-toxic attributes of these ILs, bolstering their potential as antitumor drugs. The metabolic prediction for <strong>[FM1]<sup>+</sup></strong> was consistent with its expected behavior in the biological system with its likelihood ranging from 89 % to 83 %. Additionally, <em>in silico</em> docking investigations against the protein (PDB ID: 1B38) showed that all designed ligands <strong>[FT1]<sup>+</sup></strong>, <strong>[FT2]<sup>+</sup></strong>, <strong>[FU1]<sup>+</sup></strong>, <strong>[FM1]<sup>+</sup></strong>, and <strong>[FM2]<sup>+</sup></strong> display binding affinities values of −7.82, −6.30, −6.09, −5.86, and −7.72 kcal/mol superior to both the reference and reported drug fluorouracil. Molecular dynamics (MD) simulation reinforced the docking results by utilizing root mean square deviation (RMSD) values of <strong>[FT1]<sup>+</sup></strong> varies from 0.147387 to 0.539310 Å and <strong>[FM2]<sup>+</sup></strong> lies between 0.138098 Å and 0.583763 Å and root means square fluctuation (RMSF) values for <strong>[FT1]<sup>+</sup></strong> was 0.069428–0.298235Å and <strong>[FM2]<sup>+</sup></strong> 0.070097–0.364413Å provides insight into stability and the time-dependent atomic deviations. In addition, Ramachandran plots indicate that &gt;90 % of residues occupy the favored regions supporting the protein structure stability. Thus, these analyses confirm that the newly identified ILs exhibit superior binding affinities and acceptable bioinformatics profiles, making them attractive candidates for the development of anticancer drugs.</div></div>","PeriodicalId":420,"journal":{"name":"Results in Chemistry","volume":"13 ","pages":"Article 102029"},"PeriodicalIF":2.5000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Results in Chemistry","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2211715625000128","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

Abstract

Ionic liquids (ILs) have emerged as a versatile candidate in medicinal chemistry, electrochemistry catalysis, and biotechnology. In this work, we explored the electronic interionic interactions, stability, and reactivity of FDA approved drug-based cations flutamide ([FT1]+, [FT2]+), fluorouracil ([FU1]+), and furomollugin ([FM1]+, [FM2]+), paired with amino acid [NH], nitrate [NO3], and triflate [CF3] anions, in gas and solvent phases (benzene and water). Frontiers molecular orbitals (FMOs) showed that [FT1]+[NH] exhibits the smaller Egap on both gas and solvent phase from 5.24 to 4.39 eV, suggesting high reactivity and increasing solubility. Notably, the IL pair [FT1]+[NH] possessed substantial interaction energies in the gas phase (−426.64 kcal/mol), in benzene (−390.24 kcal/mol), and in water (−369.69 kcal/mol), highlighting its potential to disrupt cancer cell growth and exhibit strong anticancer efficacy. The stability of [FT1]+[NH] was further corroborated by significant Gibbs free energy and enthalpy values (−545.30 and −560.36 kcal/mol). Bioinformatics studies reveal that our studied ILs possess superior drug-likeness along with supportive medicinal chemistry parameters. Such as, toxicity evaluation based on the TOX21 pathway confirmed the non-toxic attributes of these ILs, bolstering their potential as antitumor drugs. The metabolic prediction for [FM1]+ was consistent with its expected behavior in the biological system with its likelihood ranging from 89 % to 83 %. Additionally, in silico docking investigations against the protein (PDB ID: 1B38) showed that all designed ligands [FT1]+, [FT2]+, [FU1]+, [FM1]+, and [FM2]+ display binding affinities values of −7.82, −6.30, −6.09, −5.86, and −7.72 kcal/mol superior to both the reference and reported drug fluorouracil. Molecular dynamics (MD) simulation reinforced the docking results by utilizing root mean square deviation (RMSD) values of [FT1]+ varies from 0.147387 to 0.539310 Å and [FM2]+ lies between 0.138098 Å and 0.583763 Å and root means square fluctuation (RMSF) values for [FT1]+ was 0.069428–0.298235Å and [FM2]+ 0.070097–0.364413Å provides insight into stability and the time-dependent atomic deviations. In addition, Ramachandran plots indicate that >90 % of residues occupy the favored regions supporting the protein structure stability. Thus, these analyses confirm that the newly identified ILs exhibit superior binding affinities and acceptable bioinformatics profiles, making them attractive candidates for the development of anticancer drugs.

Abstract Image

求助全文
约1分钟内获得全文 求助全文
来源期刊
Results in Chemistry
Results in Chemistry Chemistry-Chemistry (all)
CiteScore
2.70
自引率
8.70%
发文量
380
审稿时长
56 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信